CR6856A - Agente terapeutico cristalino - Google Patents

Agente terapeutico cristalino

Info

Publication number
CR6856A
CR6856A CR6856A CR6856A CR6856A CR 6856 A CR6856 A CR 6856A CR 6856 A CR6856 A CR 6856A CR 6856 A CR6856 A CR 6856A CR 6856 A CR6856 A CR 6856A
Authority
CR
Costa Rica
Prior art keywords
crystal
therapeutic agent
polyform
pyridylsulfonyl
ethylpiperazine
Prior art date
Application number
CR6856A
Other languages
English (en)
Inventor
James Harris Laurence
Anthony Storey Richard
Shaw Wood Albert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to CR6856A priority Critical patent/CR6856A/es
Publication of CR6856A publication Critical patent/CR6856A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un poliformo de 1-(6-etoxi-5-(3-etil-6,7-dihidro-2-(2-metoxietil)-7-oxo-2H-pirazolo(4,3-d)pirimidin-5-il)-3-piridilsulfonil)-4-etilpiperazina.
CR6856A 2002-12-13 2002-12-13 Agente terapeutico cristalino CR6856A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR6856A CR6856A (es) 2002-12-13 2002-12-13 Agente terapeutico cristalino

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR6856A CR6856A (es) 2002-12-13 2002-12-13 Agente terapeutico cristalino

Publications (1)

Publication Number Publication Date
CR6856A true CR6856A (es) 2004-04-29

Family

ID=44839083

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6856A CR6856A (es) 2002-12-13 2002-12-13 Agente terapeutico cristalino

Country Status (1)

Country Link
CR (1) CR6856A (es)
  • 2002

Similar Documents

Publication Publication Date Title
MXPA03007140A (es) Derivados de carbolina.
TNSN06129A1 (fr) Derives de pyrazolyle et d'imidazolyle bicycliques et leurs utilisations
MY135233A (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
DE60130555D1 (de) 1-(heteroaryl-phenyl)-kondensierte pyrazol-derivate als factor xa inhibitoren
CY1106766T1 (el) Παραγωγα πυριδινης ως αναστολεις raf κινασης
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
ECSP045286A (es) Indazoles sustituidos con una actividad anticancerosa
UA93351C2 (uk) Похідні фталазіну як інгібітори parp
ATE427747T1 (de) Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer
SG146442A1 (en) Sulphonamide derivatives, their preparation and use as medicaments
NO20053042L (no) Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
HK1060729A1 (en) Inhibitors of cruzipain and other cysteine proteases
DE60216233D1 (en) Carbolinderivate
DK1557415T3 (da) Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens
MXPA03009750A (es) Compuestos quimicos.
MXPA02012076A (es) Compuestos quimicos.
MXPA03010761A (es) Combinaciones farmaceuticas.
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
AU2001266575A1 (en) Chemical compounds
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
EA200001010A1 (ru) Применение дексмедетомидина для седативного воздействия в отделении интенсивной терапии
MXPA02012470A (es) Inhibidores de fosfodiesterasa especificos para gmp ciclico.
ATE404602T1 (de) Wässrige polyurethanzubereitungen
UY26854A1 (es) Agente terapéutico cristalino
ATE368649T1 (de) Cyanoguanidin prodrugs

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)